TY  - GEN
AU  - Takayoshi,Kotoe
AU  - Kusaba,Hitoshi
AU  - Uenomachi,Masato
AU  - Mitsugi,Kenji
AU  - Makiyama,Chinatsu
AU  - Makiyama,Akitaka
AU  - Uchino,Keita
AU  - Shirakawa,Tsuyoshi
AU  - Shibata,Yoshihiro
AU  - Shinohara,Yudai
AU  - Inadomi,Kyoko
AU  - Tsuchihashi,Kenji
AU  - Arita,Shuji
AU  - Ariyama,Hiroshi
AU  - Esaki,Taito
AU  - Akashi,Koichi
AU  - Baba,Eishi
TI  - Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer
SN  - 1432-0843
PY  - 2017///0804
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Bevacizumab
KW  - Capecitabine
KW  - Cisplatin
KW  - Disease-Free Survival
KW  - Drug Combinations
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Intestinal Neoplasms
KW  - Intestine, Small
KW  - pathology
KW  - Japan
KW  - Leucovorin
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Organoplatinum Compounds
KW  - Oxonic Acid
KW  - Retrospective Studies
KW  - Survival Rate
KW  - Tegafur
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s00280-017-3371-0
ER  -